{"id":2918,"date":"2020-06-04T07:46:03","date_gmt":"2020-06-04T07:46:03","guid":{"rendered":"http:\/\/novalab.bold-themes.com\/demo-02\/?page_id=2918"},"modified":"2026-02-09T13:21:01","modified_gmt":"2026-02-09T12:21:01","slug":"partner","status":"publish","type":"page","link":"https:\/\/impact-acmproject.eu\/ga\/partner\/","title":{"rendered":"Comhph\u00e1irt\u00ed"},"content":{"rendered":"

<\/div><\/div>
<\/div>

P\u00e1irtn\u00e9ir<\/span><\/span><\/h1>
Comhph\u00e1irt\u00ed an tionscadail<\/div><\/header>
<\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>
\"bt_bb_section_bottom_section_coverage_image\"<\/div><\/section>
\"https:\/\/impact-acmproject.eu\/wp-content\/uploads\/2023\/11\/universita_padova.webp\"<\/span><\/div>
<\/div><\/div><\/div><\/div>

Universit\u00e0 degli Studi di Padova<\/span><\/span><\/h3><\/header>
<\/div>
<\/div>
<\/p>\n

Buna\u00edodh Roinn Bitheola\u00edochta Ollscoil Padua i m\u00ed Dheireadh F\u00f3mhair 1983 tr\u00ed ch\u00f3nascadh na nInstiti\u00faid\u00ed Bitheola\u00edochta Ainmhithe, Luibheola\u00edochta, agus Antraipeola\u00edochta, mar aon le Gaird\u00edn Luibheola\u00edoch Padua agus St\u00e1isi\u00fan Bitheola\u00edochta Mara Chioggia (an Vein\u00e9is).<\/p>\n

Mar chomhordaitheoir an tionscadail, \u00e1irith\u00edonn UNIDP go bhfuil cusp\u00f3ir\u00ed an tionscadail ail\u00ednithe le t\u00e9arma\u00ed an Chomhaontaithe Deontais agus Cuibhreannais (CA). T\u00e1 s\u00e9 de ch\u00faram air srath\u00fa othair ACM a fheabhs\u00fa, rannchuidi\u00fa athraithigh a bhfuil t\u00e1bhacht anaithnid acu a chinneadh, agus samhlacha r\u00e9amhchlinici\u00fala \u00e1bhartha a fhorbairt agus a thr\u00e9ithri\u00fa. Ina theannta sin, t\u00e1 s\u00e9 freagrach as saincheisteanna eitici\u00fala a d'fh\u00e9adfadh a bheith ann a aithint agus iad a r\u00e9iteach. Comhoibr\u00edonn UNIPD go dl\u00fath leis na comhph\u00e1irtithe freisin chun meas\u00fan\u00fa a dh\u00e9anamh ar \u00e1bhair imn\u00ed eitici\u00fala a bhfuiltear ag s\u00fail leo agus chun aghaidh a thabhairt orthu si\u00fad at\u00e1 ag teacht chun cinn le linn ch\u00farsa an tionscadail.<\/p>\n

\n<\/div>

<\/div>
su\u00edomh gr\u00e9as\u00e1in<\/span><\/a><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div>

Consorzio Italbiotec<\/span><\/span><\/h3><\/header>
<\/div>
<\/div>
<\/p>\n

An eagra\u00edocht neamhbhrab\u00fais is m\u00f3 san Iod\u00e1il in earn\u00e1il na biteicneola\u00edochta. Treora\u00edonn s\u00e9 forbairt eola\u00edoch agus aistri\u00fa \u00f3ir eolais idir an pobal taighde agus an tionscal chun \u00e9iceach\u00f3ras nu\u00e1la\u00edochta ceannr\u00f3da\u00edoch a mh\u00fanl\u00fa arna spreagadh ag gn\u00f3lachta\u00ed nuathionscanta biteicneola\u00edochta, cuideachta\u00ed, ollscoileanna ina spreagann comhar agus malart\u00fa eolais f\u00e1s agus nu\u00e1la\u00edocht inbhuanaithe. Beidh Consorzio Italbiotec, a bhu\u00ed lena shaineolas, i gceannas ar ghn\u00edomha\u00edochta\u00ed scaipthe, cumars\u00e1ide, oili\u00fana agus saothraithe agus \u00e9 mar aidhm ardleibh\u00e9il cult\u00far cumars\u00e1ide l\u00e1idir agus \u00e9ifeachtach a th\u00f3g\u00e1il agus a chothabh\u00e1il laistigh den tionscadal. Coth\u00f3idh an strait\u00e9is freisin pobal eolasach p\u00e1irtithe leasmhara agus ilghn\u00edomhaithe a bhfuil suim acu in \u00e1bhar IMPACT agus at\u00e1 tiomanta d\u00f3 agus rannchuideoidh s\u00ed leis an leas is fearr is f\u00e9idir a bhaint as a thortha\u00ed nu\u00e1lacha.<\/p>\n

\n<\/div>

<\/div>
su\u00edomh gr\u00e9as\u00e1in<\/span><\/a><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>
<\/div>
\"https:\/\/impact-acmproject.eu\/wp-content\/uploads\/2023\/11\/italbiotec.webp\"<\/span><\/div><\/div><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div>
\"https:\/\/impact-acmproject.eu\/wp-content\/uploads\/2023\/11\/maastricht.webp\"<\/span><\/div>
<\/div><\/div><\/div><\/div>

Ollscoil Maastricht<\/span><\/span><\/h3><\/header>
<\/div>
<\/div>
<\/p>\n

Is ionad tagartha domhanda \u00e9 an Scoil um Ghalair Chardashoith\u00edocha (CARIM) in Ollscoil Maastricht chun staid\u00e9ar a dh\u00e9anamh ar mheicn\u00edochta\u00ed rial\u00e1la g\u00e9ine i rial\u00fa foirmeacha g\u00e9initeacha agus faighte cliseadh cro\u00ed. \u00das\u00e1idtear samhlacha in vivo agus in vitro daonna go rialta chun staid\u00e9ar a dh\u00e9anamh ar ghalair chairdiacha dhaonna tr\u00ed chur chuige bitheola\u00edoch m\u00f3il\u00edneach agus cille a chur i bhfeidhm, chomh maith le saor\u00e1id\u00ed scagth\u00e1st\u00e1la g\u00e9initeacha tr\u00e9chuir ard, teicneola\u00edocht trasgh\u00e9ine \/ g\u00e9ine, feinit\u00edop\u00e1il chairdiach, agus teicn\u00edc\u00ed \u00edomh\u00e1ithe. \u00d3 roinnt blianta, tr\u00ed shainchomhartha ioml\u00e1n agus domhanda a shol\u00e1thar do phr\u00f3if\u00edli\u00fa microRNAnna i gcliseadh cro\u00ed, meastar go bhfuil an Institi\u00faid seo ina ceannaire sa r\u00e9imse eipiginiteach cairdiach ar fud an domhain.<\/p>\n

\n<\/div>

<\/div>
su\u00edomh gr\u00e9as\u00e1in<\/span><\/a><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div>

AccelBio<\/span><\/span><\/h3><\/header>
<\/div>
<\/div>
<\/p>\n

Is eagra\u00edocht neamhbhrab\u00fais T&F de chuid na Portaing\u00e9ile \u00e9 AccelBio a aonta\u00edonn comhph\u00e1irtithe \u00f3 ch\u00f3gaslann, biteicneola\u00edocht, saol acad\u00fail, caipiteal fiontair agus p\u00e1irc biteicneola\u00edochta.<\/p>\n

Baineann AccelBio \u00fas\u00e1id as cuir chuige r\u00e9as\u00fanacha nua chun tac\u00fa le tionscadail aistritheacha fionnachtana druga\u00ed i gc\u00e9imeanna r\u00e9amhchlinici\u00fala \u00f3n saol acad\u00fail agus \u00f3 ghn\u00f3lachta\u00ed nuathionscanta. I measc a r\u00e9ims\u00ed saineolais t\u00e1 galair chardashoith\u00edocha agus n\u00e9areola\u00edocha, imdh\u00edoneola\u00edocht, athlasadh, ionfhabht\u00fa, oinceola\u00edocht agus n\u00e9areola\u00edocht, i measc nithe eile.<\/p>\n

Chun tac\u00fa le forbairt druga\u00ed, t\u00e1 ard\u00e1in teicneola\u00edochta \u00f3stach AccelBio lena n-\u00e1ir\u00edtear ard-org\u00e1in, il-omics, bitheola\u00edocht r\u00edomhaireacht\u00fail, bithfhaisn\u00e9is\u00edocht agus scagadh ard-tr\u00e9chur. T\u00e1 an fhoireann aistritheach tiomanta freisin do thaca\u00edocht a thabhairt do thaighdeoir\u00ed agus d\u2019fhiontraithe treochl\u00e1r binse go margadh a dhearadh, ag lean\u00faint dea-chleachtais at\u00e1 bunaithe ar an tionscal agus as a dtagann iarrth\u00f3ir\u00ed druga\u00ed ar ardchaighde\u00e1n.<\/p>\n

Laistigh de IMPACT, bainfidh Accelbio \u00fas\u00e1id as a org\u00e1n\u00f3idigh chro\u00ed an duine at\u00e1 chun cinn go huath\u00fail chun srath\u00fa othair ACM a chur chun cinn agus chun meicn\u00edochta\u00ed nua gn\u00edomha\u00edochta, bithmharc\u00f3ir\u00ed agus spriocanna teiripeacha don ghalar seo a nochtadh agus a bhail\u00edocht\u00fa.<\/p>\n

\n<\/div>

<\/div>
su\u00edomh gr\u00e9as\u00e1in<\/span><\/a><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>
<\/div>
\"l\u00f3g\u00f3<\/span><\/div><\/div><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div>
\"https:\/\/impact-acmproject.eu\/wp-content\/uploads\/2023\/11\/italfarmaco.webp\"<\/span><\/div>
<\/div><\/div><\/div><\/div>

Italfarmaco Spa (ITF)<\/span><\/span><\/h3><\/header>
<\/div>
<\/div>
<\/p>\n

Is cuideachta iln\u00e1isi\u00fanta Iod\u00e1lach faoi \u00fain\u00e9ireacht phr\u00edobh\u00e1ideach \u00e9 Italfarmaco SpA a bhfuil a cheanncheathr\u00fa in Milano. Oibr\u00edonn s\u00e9 san Iod\u00e1il agus thar lear sna hearn\u00e1lacha c\u00f3gais\u00edochta agus c\u00f3gais\u00edochta ceimiceacha tr\u00ed chuideachta\u00ed a bhfuil leas d\u00edreach n\u00f3 ind\u00edreach aige iontu. Buna\u00edodh Italfarmaco i 1938. T\u00e1 saor\u00e1id\u00ed tionscla\u00edocha nua-aimseartha ag an nGr\u00fapa chun t\u00e1irg\u00ed c\u00f3gais\u00edochta ar ardchaighde\u00e1n a th\u00e1irgeadh agus t\u00e1 tiomantas l\u00e1idir aige do thaighde, go h\u00e1irithe sna r\u00e9ims\u00ed cardashoith\u00edocha, imdh\u00edoneola\u00edocha agus oinceola\u00edocha.
\nLaistigh de IMPACT, beidh ITF freagrach as forbairt druga\u00ed agus meas\u00fanachta\u00ed scagtha druga\u00ed agus oibreoidh s\u00e9 chun ceimit\u00edopa\u00ed n\u00fa\u00edosacha cos\u00fail le druga\u00ed a aithint leis an bpr\u00f3if\u00edl at\u00e1 ag teast\u00e1il.<\/p>\n

\n<\/div>

<\/div>
su\u00edomh gr\u00e9as\u00e1in<\/span><\/a><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div>

UMC Utrecht<\/span><\/span><\/h3><\/header>
<\/div>
<\/div>
<\/p>\n

Ollscoil Leighis Ionad Utrecht (UMC Utrecht) Is go n\u00e1isi\u00fanta agus go hidirn\u00e1isi\u00fanta
\nl\u00e1rionad saineolais aitheanta do ghalair cro\u00ed a fhaightear le hoidhreacht. T\u00e1 s\u00e9 ina \u00f3stach ar bithbhanc m\u00f3r de
\nfuil agus f\u00edoch\u00e1n (bith\u00f3ipse, autopsy, trasphland\u00fa) othar cardiomyopathy. UMC
\nFeidhm\u00edonn Utrecht mar ionad n\u00e1isi\u00fanta atreoraithe d'othair a bhfuil arrhythmic orthu
\ncardiomyopathy (ACM) agus comhorda\u00edonn s\u00e9 cl\u00e1rlann n\u00e1isi\u00fanta d'othair ACM (an
\nCl\u00e1rlann ACM na h\u00cdsilt\u00edre) lena n-\u00e1ir\u00edtear > 2000 othar ACM faoi l\u00e1thair agus
\ngaolta.<\/p>\n

Laistigh de IMPACT, tabharfaidh UMC Utrecht sonra\u00ed isteach \u00f3 othair at\u00e1 san \u00e1ireamh san ACM
\ncl\u00e1rlann chun braisl\u00ed othar a \u00fas\u00e1ideann intleacht shaorga a shainaithint. An m\u00e9id a sainaithn\u00edodh
\nd\u00e9anfar braisl\u00ed a bhail\u00edocht\u00fa idir m\u00f3d\u00falachta\u00ed (ECG, \u00edomh\u00e1\u00fa cairdiach, bithshampla\u00ed). In
\nIna theannta sin, d\u00e9anfaidh UMC Utrecht ardstaid\u00e9ir -\u00f3maice ar shampla\u00ed f\u00edoch\u00e1in ACM,
\nlena n-\u00e1ir\u00edtear tras-scr\u00edbhinn n\u00faicl\u00e9as aonair, gabh\u00e1il in situ, seicheamh\u00fa RNA agus
\npr\u00f3it\u00e9ama\u00edocht. Cuirfear na tortha\u00ed sin san \u00e1ireamh ina dhiaidh sin i bpac\u00e1ist\u00ed oibre eile chun an m\u00e9id seo a leanas a shainaithint:
\nspriocanna f\u00e9ideartha druga\u00ed.<\/p>\n

\n<\/div>

<\/div>
su\u00edomh gr\u00e9as\u00e1in<\/span><\/a><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>
<\/div>
\"UMC<\/span><\/div><\/div><\/div><\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div>
\"Lutech\"<\/span><\/div>
<\/div><\/div><\/div><\/div>

Lutech Advanced Solutions SPA (LUTECH)<\/span><\/span><\/h3><\/header>
<\/div>
<\/div>
<\/p>\n

Seasann Lutech Advanced Solutions amach mar phr\u00edomhshol\u00e1thra\u00ed r\u00e9itigh teicneola\u00edochta, a bhfuil c\u00e1il air as a sheirbh\u00eds\u00ed TF nu\u00e1lacha agus chun cinn. Le b\u00e9im ar leith ar r\u00e9itigh cheannr\u00f3da\u00edocha, sol\u00e1thra\u00edonn an chuideachta raon leathan seirbh\u00eds\u00ed, \u00f3 chlaochl\u00fa digiteach agus cibearshl\u00e1nd\u00e1il go n\u00e9alr\u00edomhaireacht agus anail\u00eds\u00edocht sonra\u00ed. Laistigh de thionscadal IMPACT, t\u00e1 Lutech tiomanta d'fheinit\u00edop\u00e1il agus d'\u00e1irgi\u00falacht chlinici\u00fail samhlacha r\u00e9amhchlinici\u00fala a fheabhs\u00fa. Is \u00e9 an aidhm at\u00e1 ann intuarthacht na gcine\u00e1lacha cur chuige teiripeacha a ard\u00fa i staid\u00e9ir chlinici\u00fala agus i mbainisti\u00fa galar. Ina theannta sin, t\u00e1 baint ghn\u00edomhach ag Lutech le samhlacha l\u00e1idre r\u00e9amhchlinici\u00fala a fhorbairt agus a thr\u00e9ithri\u00fa, rud a chuireann le cur chun cinn forioml\u00e1n modheola\u00edochta\u00ed agus tortha\u00ed taighde.<\/p>\n

\n<\/div>

<\/div>
su\u00edomh gr\u00e9as\u00e1in<\/span><\/a><\/div>
<\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/section>
<\/div><\/div>
<\/div><\/div><\/div><\/section><\/p>","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-2918","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/impact-acmproject.eu\/ga\/wp-json\/wp\/v2\/pages\/2918","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/impact-acmproject.eu\/ga\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/impact-acmproject.eu\/ga\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/impact-acmproject.eu\/ga\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/impact-acmproject.eu\/ga\/wp-json\/wp\/v2\/comments?post=2918"}],"version-history":[{"count":32,"href":"https:\/\/impact-acmproject.eu\/ga\/wp-json\/wp\/v2\/pages\/2918\/revisions"}],"predecessor-version":[{"id":4057,"href":"https:\/\/impact-acmproject.eu\/ga\/wp-json\/wp\/v2\/pages\/2918\/revisions\/4057"}],"wp:attachment":[{"href":"https:\/\/impact-acmproject.eu\/ga\/wp-json\/wp\/v2\/media?parent=2918"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}